SNCG and supranuclear palsy, progressive, 1: Similarly, Vaughan and co-authors utilized SAA to examine α-synuclein aggregates in CSF samples from patients with PSP and CBS, aiming to investigate the clinicopathological features of α-synuclein in these disorders [77].